Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 12
Submit an article Journal homepage
327
Views
11
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma

Oscar CalzadaDepartment of Hematology and Medical Oncology, Emory University – Winship Cancer Institute, Atlanta, GA, USA; View further author information
,
Jeffrey M. SwitchenkoDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA; View further author information
,
Joseph J. MalyThe Ohio State University – James Comprehensive Cancer Center, Columbus, OH, USA; View further author information
,
Kristie A. BlumThe Ohio State University – James Comprehensive Cancer Center, Columbus, OH, USA; View further author information
,
Natalie GroverLineberger Cancer Center – University of North Carolina, Chapel Hill, NC, USA; View further author information
,
Stephanie MathewsLineberger Cancer Center – University of North Carolina, Chapel Hill, NC, USA; View further author information
,
Steven I. ParkLineberger Cancer Center – University of North Carolina, Chapel Hill, NC, USA; View further author information
,
Max GordonOregon Health Sciences University, Portland, OR, USA; View further author information
,
Alexey DanilovOregon Health Sciences University, Portland, OR, USA; View further author information
,
Narendranath EpperlaDivision of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Timothy S. FenskeDivision of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Mehdi HamadaniDivision of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Christopher R. FlowersDepartment of Hematology and Medical Oncology, Emory University – Winship Cancer Institute, Atlanta, GA, USA; View further author information
&
Jonathon B. CohenDepartment of Hematology and Medical Oncology, Emory University – Winship Cancer Institute, Atlanta, GA, USA; Correspondence[email protected]
View further author information
 show all
Pages 2862-2870 | Received 21 Mar 2017, Accepted 13 Mar 2018, Published online: 18 Jun 2018

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wern Lynn Ng, Yucai Wang, Allison M. Bock, Dragan Jevremovic, Michael L. Wang & Grzegorz S. Nowakowski. (2023) Review of management options for mantle cell lymphoma in pregnancy. Leukemia & Lymphoma 64:6, pages 1194-1198.
Read now
Tadeusz Robak, Piotr Smolewski, Pawel Robak & Martin Dreyling. (2019) Mantle cell lymphoma: therapeutic options in transplant-ineligible patients. Leukemia & Lymphoma 60:11, pages 2622-2634.
Read now

Articles from other publishers (9)

Tingxun Lu, Jie Zhang, Jenna M. McCracken & Ken H. Young. (2024) Recent advances in genomics and therapeutics in mantle cell lymphoma. Cancer Treatment Reviews 122, pages 102651.
Crossref
Matthew R. Wilson, Aisling Barrett, Chan Yoon Cheah & Toby A. Eyre. (2023) How I manage mantle cell lymphoma: indolent versus aggressive disease. British Journal of Haematology 201:2, pages 185-198.
Crossref
Lindsay Hammons & Timothy S. Fenske. (2022) Treatment of Mantle Cell Lymphoma in the Frontline Setting: Are We Ready for a Risk-Adapted Approach?. Journal of Personalized Medicine 12:7, pages 1134.
Crossref
Eva Giné, Fátima de la Cruz, Ana Jiménez Ubieto, Javier López Jimenez, Alejandro Martín García-Sancho, M. José Terol, Eva González Barca, María Casanova, Adolfo de la Fuente, Ana Marín-Niebla, Ana Muntañola, Tomás José González-López, Marta Aymerich, Xavier Setoain, Montserrat Cortés-Romera, Amanda Rotger, Sonia Rodríguez, Alejandro Medina Herrera, Ramón García Sanz, Ferran Nadeu, Silvia Beà, Elías Campo & Armando López-Guillermo. (2022) Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial. Journal of Clinical Oncology 40:11, pages 1196-1205.
Crossref
Alessia CastellinoYucai Wang, Melissa C. LarsonMatthew J. Maurer, Brian K. Link, Umar FarooqAndrew L. Feldman, Sergei I. SyrbuThomas M. HabermannJonas Paludo, David J. InwardsThomas E. Witzig, Stephen M. AnsellCristine AllmerSusan L. SlagerJonathon B. Cohen, Peter Martin, James R. Cerhan & Grzegorz S. Nowakowski. (2022) Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes. Blood Advances 6:4, pages 1350-1360.
Crossref
Krithika Shanmugasundaram, Subir Goyal, Jeffery Switchenko, Oscar Calzada, Michael C. Churnetski, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, Narendranath Epperla, David A. Bond, Talha Badar, Kristie A. Blum, Mehdi Hamadani, Timothy S. Fenske, Mary Malecek, Brad S. Kahl, Peter Martin, Jin Guo, Christopher R. Flowers & Jonathon B. Cohen. (2021) Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival. European Journal of Haematology 107:3, pages 301-310.
Crossref
Christina Lee & Peter Martin. (2020) Watch and Wait in Mantle Cell Lymphoma. Hematology/Oncology Clinics of North America 34:5, pages 837-847.
Crossref
Emily Fay, Daniel Herzig, Kaveh Sharzehi & Stephen E. Spurgeon. (2020) The First Report of Endoscopic Ultrasound-guided Intralesional Rituximab in a Patient With Mantle Cell Lymphoma Presenting With Isolated Colorectal Involvement. Clinical Lymphoma Myeloma and Leukemia 20:8, pages e485-e487.
Crossref
Edward A. Nabrinsky & Alexey V. Danilov. 2020. Follicular Lymphoma and Mantle Cell Lymphoma. Follicular Lymphoma and Mantle Cell Lymphoma 163 177 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.